Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brophy

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Annals of Internal Medicine|December 19, 2012
ACP Journal Club. Review: low-quality evidence fails to show that antihypertensive drugs affect outcomes in mild hypertensionJames Brophy
Annals of Internal Medicine|January 20, 2010
ACP Journal Club. A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspneaJames Brophy
Annals of Internal Medicine|September 23, 2018
Guideline: 11 professional organizations made 106 recommendations for management of high blood pressure in adultsJames Brophy
Annals of Internal Medicine|October 19, 2020
In adults with chest pain, a troponin limit of detection strategy did not increase early discharge rateJames Brophy
Annals of Internal Medicine|January 24, 2017
Review: In type 2 diabetes, sodium-glucose cotransporter 2 inhibitors do not increase major CV events or mortalityJames Brophy
Annals of Internal Medicine|August 18, 2015
ACP Journal Club: transcatheter and surgical aortic valve replacement did not differ for mortality in severe aortic stenosisJames Brophy
Annals of Internal Medicine|August 18, 2015
ACP Journal Club: transcatheter aortic valve replacement reduced mortality more than usual care in inoperable severe aortic stenosisJames Brophy
Annals of Internal Medicine|December 4, 2023
In symptomatic AF with end-stage HF, adding catheter ablation to medical therapy improved clinical outcomes at 18 moJames Brophy
Annals of Internal Medicine|September 23, 2018
Review: In hypertension, intensive BP goals reduce CV events; self vs office BP measures do not improve BP at 12 moJames Brophy
Annals of Internal Medicine|December 18, 2018
In high-risk obese or overweight patients, lorcaserin did not increase or decrease CV events at 3.3 yearsJames Brophy
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Annals of Internal Medicine|December 19, 2012
ACP Journal Club. Review: low-quality evidence fails to show that antihypertensive drugs affect outcomes in mild hypertensionJames Brophy
Annals of Internal Medicine|January 20, 2010
ACP Journal Club. A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspneaJames Brophy
Annals of Internal Medicine|September 23, 2018
Guideline: 11 professional organizations made 106 recommendations for management of high blood pressure in adultsJames Brophy
Annals of Internal Medicine|October 19, 2020
In adults with chest pain, a troponin limit of detection strategy did not increase early discharge rateJames Brophy
Annals of Internal Medicine|January 24, 2017
Review: In type 2 diabetes, sodium-glucose cotransporter 2 inhibitors do not increase major CV events or mortalityJames Brophy
Annals of Internal Medicine|August 18, 2015
ACP Journal Club: transcatheter and surgical aortic valve replacement did not differ for mortality in severe aortic stenosisJames Brophy
Annals of Internal Medicine|August 18, 2015
ACP Journal Club: transcatheter aortic valve replacement reduced mortality more than usual care in inoperable severe aortic stenosisJames Brophy
Annals of Internal Medicine|December 4, 2023
In symptomatic AF with end-stage HF, adding catheter ablation to medical therapy improved clinical outcomes at 18 moJames Brophy
Annals of Internal Medicine|September 23, 2018
Review: In hypertension, intensive BP goals reduce CV events; self vs office BP measures do not improve BP at 12 moJames Brophy
Annals of Internal Medicine|December 18, 2018
In high-risk obese or overweight patients, lorcaserin did not increase or decrease CV events at 3.3 yearsJames Brophy
Pageof 6